.Cordis is an independent, customer-focused provider of interventional cardiovascular technologies.During our 60-year history we've established a legacy of pioneering breakthrough technologies, including the first guiding catheters and coronary drug eluting stents. Cordis has built a strong global footprint that spans 70 countries.We remain committed to saving millions of lives through innovation, clinical acumen, training, and service. Our mission is to delight customers by developing differentiated solutions at pace that improve patient vitality and help lower the cost of care.We never stop innovating. We will continue to focus on vascular closure, radial, pedal access, and intervention as we look to the future to address the toughest cardiovascular challenges.When we make progress – in R&D, company culture, clinical outcomes, or operational discipline – so do our customers, patients, teammates, and shareholders. We're unleashing our potential so that our customer can do the same.A dynamic new business modelWith new investment partners and a strong, seasoned executive leadership team, we are reinventing ourselves and revitalizing the Cordis brand with our customers at the center of it.In collaboration with Cordis X, an independent innovation accelerator with a go-to-market model built for speed, agility and value maximization, we are ready to push the envelope and iterate at pace with the market.Hellman & Friedman, LLCHellman & Friedman, LLC is a U.S.-based global private equity firm with a distinctive investment approach focused on large-scale equity investments in high quality growth businesses. H&F seeks to partner with world-class management teams where its deep sector expertise, long-term orientation and collaborative partnership approach enable companies to flourish. H&F targets outstanding businesses in select sectors including healthcare, software and technology, financial services, consumer and retail, and other business services.Since its founding in 1984, H&F has invested in over 100 companies. The firm is currently investing its tenth fund, with $24.4 billion of committed capital and has over $95 billion in assets under management as of September 30, 2021.KKRKKR (NYSE: KKR) is a private equity firm focused on generating attractive investment returns by following a patient and disciplined investment approach, employing over 800 world-class people, and supporting growth in its 110 portfolio companies and communities. Together, they generate more than $269 billion in annual revenues. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR's insurance subsidiaries offer retirement, life and reinsurance products under the management of The Global Atlantic Financial Group. References to KKR's investments may include the activities of its sponsored funds and insurance subsidiaries
